Right portal vein embolization (PVE) was performed in patients in need
of wide hepatectomy to induce preoperative hypertrophy of the future
remnant liver (FRL), which would have been insufficient for safe resec
tion. PVE was achieved with cyanoacrylat or gelatin sponges by using a
percutaneous subxiphoid approach in 10 patients with tumors in noncir
rhotic liver. Surgery was performed in nine patients 17-48 days (mean,
34 days) after PVE. Computed tomographic liver volumetric studies wer
e performed before embolization and before surgery. Clinical and biolo
gic tolerance of PVE was excellent except in one case. Histopathologic
studies showed occlusion of portal veins with minimal parenchymal isc
hemia in eight of nine patients. The FRL volume increased by 64%, whic
h represented 31% of the preresection volume of the liver. Better hype
rtrophy was seen after cyanoacrylat embolization. The authors conclude
that PVE is safe and well tolerated and induces marked hypertrophy of
the unembolized parenchyma in noncirrhotic patients. This hypertrophy
allows hepatectomy to be performed under safe conditions when the FRL
volume is initially insufficient.